E Vielhaber
Overview
Explore the profile of E Vielhaber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vielhaber E, Virshup D
IUBMB Life
. 2001 Jul;
51(2):73-8.
PMID: 11463166
The casein kinase I (CKI) family of protein kinases is a group of highly related, ubiquitously expressed serine/threonine kinases found in all eukaryotic organisms from protozoa to man. Recent advances...
2.
Vielhaber E, Eide E, Rivers A, Gao Z, Virshup D
Mol Cell Biol
. 2000 Jun;
20(13):4888-99.
PMID: 10848614
The molecular oscillator that keeps circadian time is generated by a negative feedback loop. Nuclear entry of circadian regulatory proteins that inhibit transcription from E-box-containing promoters appears to be a...
3.
Ketterling R, Vielhaber E, Li X, Drost J, Schaid D, Kasper C, et al.
Hum Genet
. 2000 Jan;
105(6):629-40.
PMID: 10647899
The factor IX gene (F9) is an advantageous system for analyzing recent spontaneous germline mutation in humans. Herein, the male:female ratio of mutation ("r") in F9 have been estimated by...
4.
Rivers A, Gietzen K, Vielhaber E, Virshup D
J Biol Chem
. 1998 Jun;
273(26):15980-4.
PMID: 9632646
Casein kinase I delta (CKIdelta) and casein kinase I epsilon (CKIepsilon) have been implicated in the response to DNA damage, but the understanding of how these kinases are regulated remains...
5.
Ketterling R, Vielhaber E, Sommer S
Am J Hum Genet
. 1994 May;
54(5):831-5.
PMID: 8178822
We have identified eight independent transversions at CpG in 290 consecutive families with hemophilia B. These eight transversions account for 16.3% of all independent transversions in our sample, yet the...
6.
Vielhaber E, Sommer S, Freedenberg D
Am J Med Genet
. 1994 Jan;
49(2):257-8.
PMID: 8116680
No abstract available.
7.
Caglayan S, Vielhaber E, Gursel T, Aktuglu G, Sommer S
Hum Mutat
. 1994 Jan;
4(2):163-5.
PMID: 7981722
No abstract available.
8.
Vielhaber E, Jacobson D, Ketterling R, Liu J, Sommer S
Hum Mol Genet
. 1993 Aug;
2(8):1309-10.
PMID: 8401514
No abstract available.
9.
Bottema C, Ketterling R, Vielhaber E, Yoon H, Gostout B, Jacobson D, et al.
Hum Genet
. 1993 Jun;
91(5):496-503.
PMID: 8314564
Mutations at CpG dinucleotides were delineated in the factor IX gene of 38 hemophilia B patients. When transitions at CpG were considered with those previously reported by us and those...
10.
Gostout B, Vielhaber E, Ketterling R, Yoon H, Bottema C, Kasper C, et al.
Hum Mol Genet
. 1993 Mar;
2(3):293-8.
PMID: 8499919
DNA samples of patients from around the world have been sequenced to precisely define the mutations in the factor IX gene resulting in hemophilia B. This study compares the patterns...